Female, 33 y.o.
History: in Jan 2013 diagnosed with mediastinum mass 4 cm. Tumor was revealed accidentally. There were no any other symptoms (like fever, weight lose and so on). Diagnosis of tymoma was made. Also there was no treatment, only medical follow-up. Biopsy was nor performed.
Currently in April 2014 she returned to the hospital for the exam. Mediastinum mass has slightly increased in size (accurate size is unavailable) with invasion of left lung upper lobe. There were no any other symptoms. Diagnosis of tymoma was made. Patient underwent surgery. Tumor with lung tissue was removed.
Histology and IHC data: DLBCL with CD99 expression.
Question: is it possible for patient with such lymphoma type to live 1.5 year without treatment?
Article Clinicopathologic Characteristics of CD99-Positive Diffuse L...
I saw similar case in my practise.
Unfortunately, it was refusing treatment one my patient.
However, syndrome vena cava superior and involvement soft tissue developed during the 8 months.
We got patient agreement for biopsy and treatment.
After biopsy and IHC verification PMBL patient was treated R-CHOD-R-EDHAP regimen, achieved CR and alive now.
Lymphomas therapeutics are very effective with radiotherapy.
Leuk Lymphoma. 2014 Jul 3:1-18. [Epub ahead of print]
Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with Stage I Diffuse Large B-Cell Lymphoma.
Shah BK, Bista A, Shafii B.
Abstract
ABSTRACT Disparities in cancer care have been documented, however, less is known about the disparities in diffuse large B-cell lymphoma (DLBCL). We reviewed the Surveillance, Epidemiology, and End Results database to evaluate disparities in receipt of radiotherapy (RT), and relative survival among patients diagnosed with stage I DLBCL between 1998 and 2008 on the basis of age, sex and ethnicity. African Americans and other races were significantly less likely to receive RT compared to Caucasians [adjusted odds ratio (OR) of 0.743 and 0.81, respectively]. Similarly, age 60+ years and males were less likely to receive radiotherapy compared to their counterparts (P
- Badges
- Science topic